Search research articles
Contact Us
Filters
Showing results (151-160 of 194) with videos related to
Page
of 20
Sort By:
Journal of Primary Health Care
|
December 2, 2011
Can the prevalence of diagnosed diabetes be estimated from linked national health records? The validity of a method applied in New Zealand
Simon Thornley, Craig Wright, Roger Marshall, et al.
The New Zealand Medical Journal
|
September 30, 2020
Ethnic differences in cardiovascular risk profiles among 475,241 adults in primary care in Aotearoa, New Zealand
Vanessa Selak, Katrina Poppe, Corina Grey, et al.
The New Zealand Medical Journal
|
February 27, 2010
Performance of Framingham cardiovascular risk scores by ethnic groups in New Zealand: PREDICT CVD-10
Tania Riddell, Sue Wells, Rod Jackson, et al.
Annals of Internal Medicine
|
September 17, 2019
Personalized Prediction of Cardiovascular Benefits and Bleeding Harms From Aspirin for Primary Prevention: A Benefit-Harm Analysis
Vanessa Selak, Rod Jackson, Katrina Poppe, et al.
Heart, Lung & Circulation
|
August 23, 2022
Guideline-Directed Medical Therapy Before and After Primary Prevention Implantable Cardioverter Defibrillator Implantation in New Zealand (ANZACS-QI 66)
Fang Shawn Foo, Mildred Lee, Katrina K Poppe, et al.
Heart (British Cardiac Society)
|
December 12, 2019
Development and validation of a cardiovascular risk score for patients in the community after acute coronary syndrome
Katrina K Poppe, Rob N Doughty, Susan Wells, et al.
Annals of Work Exposures and Health
|
October 9, 2021
Ischaemic Heart Disease and Occupational Exposures: A Longitudinal Linkage Study in the General and Māori Populations of New Zealand
Lucy A Barnes, Amanda Eng, Marine Corbin, et al.
Heart, Lung & Circulation
|
July 26, 2025
Long-Term Clinical Outcomes and Predictors of Mortality in Implantable Cardioverter-Defibrillator Recipients in New Zealand (ANZACS-QI 83)
Fang Shawn Foo, Mildred Lee, Wil Harrison, et al.
The New Zealand Medical Journal
|
November 27, 2012
Understanding the new HbA1c units for the diagnosis of Type 2 diabetes
Geoff D Braatvedt, Tim Cundy, Michael Crooke, et al.
The New Zealand Medical Journal
|
May 18, 2018
Is general practice identification of prior cardiovascular disease at the time of CVD risk assessment accurate and does it matter?
Sue Wells, Katrina Poppe, Vanessa Selak, et al.
Page
of 20
Search research articles
Search
Showing results (151-160 of 194) with videos related to
Sort By:
Page
of 20
Journal of Primary Health Care
|
December 2, 2011
Can the prevalence of diagnosed diabetes be estimated from linked national health records? The validity of a method applied in New Zealand
Simon Thornley, Craig Wright, Roger Marshall, et al.
The New Zealand Medical Journal
|
September 30, 2020
Ethnic differences in cardiovascular risk profiles among 475,241 adults in primary care in Aotearoa, New Zealand
Vanessa Selak, Katrina Poppe, Corina Grey, et al.
The New Zealand Medical Journal
|
February 27, 2010
Performance of Framingham cardiovascular risk scores by ethnic groups in New Zealand: PREDICT CVD-10
Tania Riddell, Sue Wells, Rod Jackson, et al.
Annals of Internal Medicine
|
September 17, 2019
Personalized Prediction of Cardiovascular Benefits and Bleeding Harms From Aspirin for Primary Prevention: A Benefit-Harm Analysis
Vanessa Selak, Rod Jackson, Katrina Poppe, et al.
Heart, Lung & Circulation
|
August 23, 2022
Guideline-Directed Medical Therapy Before and After Primary Prevention Implantable Cardioverter Defibrillator Implantation in New Zealand (ANZACS-QI 66)
Fang Shawn Foo, Mildred Lee, Katrina K Poppe, et al.
Heart (British Cardiac Society)
|
December 12, 2019
Development and validation of a cardiovascular risk score for patients in the community after acute coronary syndrome
Katrina K Poppe, Rob N Doughty, Susan Wells, et al.
Annals of Work Exposures and Health
|
October 9, 2021
Ischaemic Heart Disease and Occupational Exposures: A Longitudinal Linkage Study in the General and Māori Populations of New Zealand
Lucy A Barnes, Amanda Eng, Marine Corbin, et al.
Heart, Lung & Circulation
|
July 26, 2025
Long-Term Clinical Outcomes and Predictors of Mortality in Implantable Cardioverter-Defibrillator Recipients in New Zealand (ANZACS-QI 83)
Fang Shawn Foo, Mildred Lee, Wil Harrison, et al.
The New Zealand Medical Journal
|
November 27, 2012
Understanding the new HbA1c units for the diagnosis of Type 2 diabetes
Geoff D Braatvedt, Tim Cundy, Michael Crooke, et al.
The New Zealand Medical Journal
|
May 18, 2018
Is general practice identification of prior cardiovascular disease at the time of CVD risk assessment accurate and does it matter?
Sue Wells, Katrina Poppe, Vanessa Selak, et al.
Page
of 20